Breaking News

Yesterday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Recommendations
Roche price target raised to CHF 395 from CHF 375 at Barclays » 11:18
07/23/21
07/23
11:18
07/23/21
11:18
RHHBY

Roche

$46.42 /

-2.07 (-4.27%)

Barclays analyst Emmanuel…

Barclays analyst Emmanuel Papadakis raised the firm's price target on Roche to CHF 395 from CHF 375 and keeps an Overweight rating on the shares.

ShowHide Related Items >><<
RHHBY Roche
$46.42 /

-2.07 (-4.27%)

RHHBY Roche
$46.42 /

-2.07 (-4.27%)

07/22/21 UBS
Roche price target raised to CHF 375 from CHF 330 at UBS
07/19/21 UBS
Roche price target raised to CHF 345 from CHF 330 at UBS
07/14/21 Jefferies
Roche upgraded to Buy from Hold at Jefferies
07/13/21 Piper Sandler
Bicycle Therapeutics price target raised to $46 from $39 at Piper Sandler
RHHBY Roche
$46.42 /

-2.07 (-4.27%)

RHHBY Roche
$46.42 /

-2.07 (-4.27%)

RHHBY Roche
$46.42 /

-2.07 (-4.27%)

Thursday
Recommendations
Roche price target raised to CHF 375 from CHF 330 at UBS » 15:01
07/22/21
07/22
15:01
07/22/21
15:01
RHHBY

Roche

$48.49 /

+0.41 (+0.85%)

UBS analyst Michael…

UBS analyst Michael Leuchten raised the firm's price target on Roche to CHF 375 from CHF 330 and keeps a Neutral rating on the shares.

ShowHide Related Items >><<
RHHBY Roche
$48.49 /

+0.41 (+0.85%)

RHHBY Roche
$48.49 /

+0.41 (+0.85%)

07/19/21 UBS
Roche price target raised to CHF 345 from CHF 330 at UBS
07/14/21 Jefferies
Roche upgraded to Buy from Hold at Jefferies
07/13/21 Piper Sandler
Bicycle Therapeutics price target raised to $46 from $39 at Piper Sandler
07/08/21 Deutsche Bank
Roche upgraded to Buy from Hold at Deutsche Bank
RHHBY Roche
$48.49 /

+0.41 (+0.85%)

RHHBY Roche
$48.49 /

+0.41 (+0.85%)

RHHBY Roche
$48.49 /

+0.41 (+0.85%)

Hot Stocks
Roche confirms outlook for FY21 » 06:24
07/22/21
07/22
06:24
07/22/21
06:24
RHHBY

Roche

$48.49 /

+0.41 (+0.85%)

Despite the continued…

Despite the continued strong impact of biosimilars, sales are expected to grow in the low- to mid-single digit range, at constant exchange rates. Core earnings per share are targeted to grow broadly in line with sales, at constant exchange rates. Roche expects to increase its dividend in Swiss francs further.

ShowHide Related Items >><<
RHHBY Roche
$48.49 /

+0.41 (+0.85%)

RHHBY Roche
$48.49 /

+0.41 (+0.85%)

07/19/21 UBS
Roche price target raised to CHF 345 from CHF 330 at UBS
07/14/21 Jefferies
Roche upgraded to Buy from Hold at Jefferies
07/13/21 Piper Sandler
Bicycle Therapeutics price target raised to $46 from $39 at Piper Sandler
RHHBY Roche
$48.49 /

+0.41 (+0.85%)

RHHBY Roche
$48.49 /

+0.41 (+0.85%)

RHHBY Roche
$48.49 /

+0.41 (+0.85%)

Earnings
Roche reports 1H21 core EPS CHF10.56 vs. CHF10.44 last year » 06:24
07/22/21
07/22
06:24
07/22/21
06:24
RHHBY

Roche

$48.49 /

+0.41 (+0.85%)

Reports 1H21 group sales…

Reports 1H21 group sales CHF30.71B vs. CHF29.281B last year. Sales in the Pharmaceuticals Division were CHF 22 billion, a decrease of 3%. However, while sales in the first quarter were still strongly affected by COVID-19, the second quarter showed signs of recovery in some regions. The Diagnostics Division achieved sales growth of 51% to CHF 9 billion. Commenting on the Group's performance in the first six months, Roche CEO Severin Schwan said: "We have achieved good results in the first half, primarily thanks to the demand for our new medicines and COVID-19 tests. The Pharma Division began to grow again in the second quarter. The base diagnostics business shows strong momentum. As expected, demand for COVID-19 tests peaked in the second quarter. I'm particularly excited about the significant progress we made in our product pipeline, including very promising study results for Tecentriq in early-stage lung cancer, as well as additional positive data for Evrysdi in spinal muscular atrophy and for COVID-19 medicines. Based on the good results of the first half of 2021, we confirm the outlook for the full year."

ShowHide Related Items >><<
RHHBY Roche
$48.49 /

+0.41 (+0.85%)

RHHBY Roche
$48.49 /

+0.41 (+0.85%)

07/19/21 UBS
Roche price target raised to CHF 345 from CHF 330 at UBS
07/14/21 Jefferies
Roche upgraded to Buy from Hold at Jefferies
07/13/21 Piper Sandler
Bicycle Therapeutics price target raised to $46 from $39 at Piper Sandler
RHHBY Roche
$48.49 /

+0.41 (+0.85%)

RHHBY Roche
$48.49 /

+0.41 (+0.85%)

RHHBY Roche
$48.49 /

+0.41 (+0.85%)

Wednesday
Hot Stocks
Genentech receives breakthrough therapy designation for Venclexta combination » 05:44
07/21/21
07/21
05:44
07/21/21
05:44
RHHBY

Roche

$48.08 /

-0.47 (-0.97%)

Genentech, a member of…

Genentech, a member of Roche, announced that Venclexta in combination with azacitidine has been granted breakthrough therapy designation by the FDA for the treatment of adult patients with previously untreated intermediate, high- and very high-risk myelodysplastic syndromes based on the revised International Prognostic Scoring System.

ShowHide Related Items >><<
RHHBY Roche
$48.08 /

-0.47 (-0.97%)

RHHBY Roche
$48.08 /

-0.47 (-0.97%)

07/19/21 UBS
Roche price target raised to CHF 345 from CHF 330 at UBS
07/14/21 Jefferies
Roche upgraded to Buy from Hold at Jefferies
07/13/21 Piper Sandler
Bicycle Therapeutics price target raised to $46 from $39 at Piper Sandler
07/08/21 Deutsche Bank
Roche upgraded to Buy from Hold at Deutsche Bank
RHHBY Roche
$48.08 /

-0.47 (-0.97%)

RHHBY Roche
$48.08 /

-0.47 (-0.97%)

RHHBY Roche
$48.08 /

-0.47 (-0.97%)

Tuesday
Hot Stocks
Roche announces Japan approves Ronapreve for mild to moderate COVID-19 » 06:49
07/20/21
07/20
06:49
07/20/21
06:49
RHHBY

Roche

$48.55 /

-0.08 (-0.16%)

Roche announced that…

Roche announced that Japan's Ministry of Health, Labour and Welfare, or MHLW, has approved Ronapreve for the treatment of patients with mild to moderate COVID-19 via intravenous infusion. The antibody combination was granted a Special Approval Pathway under article 14-3 of the Pharmaceuticals and Medical Devices Act. Outside Japan, the antibody combination has been authorized for emergency use or temporary pandemic use in additional territories and regions, including in the European Union, United States, India, Switzerland and Canada. It is also undergoing rolling review by the European Medicines Agency and was granted a scientific opinion by the Committee for Medicinal Products for Human Use, supporting its use as a treatment option for patients with confirmed COVID-19 who do not require oxygen supplementation and who are at high risk of progressing to severe COVID-19. "In December 2020, Chugai obtained development and exclusive commercialization rights in Japan from Roche, and is working with the Japanese government to ensure an appropriate and timely supply of Ronapreve. In these exceptional times, Roche stands together with society, governments, healthcare providers and all those working to overcome the pandemic," the company said.

ShowHide Related Items >><<
RHHBY Roche
$48.55 /

-0.08 (-0.16%)

RHHBY Roche
$48.55 /

-0.08 (-0.16%)

07/19/21 UBS
Roche price target raised to CHF 345 from CHF 330 at UBS
07/14/21 Jefferies
Roche upgraded to Buy from Hold at Jefferies
07/13/21 Piper Sandler
Bicycle Therapeutics price target raised to $46 from $39 at Piper Sandler
07/08/21 Deutsche Bank
Roche upgraded to Buy from Hold at Deutsche Bank
RHHBY Roche
$48.55 /

-0.08 (-0.16%)

RHHBY Roche
$48.55 /

-0.08 (-0.16%)

RHHBY Roche
$48.55 /

-0.08 (-0.16%)

Monday
Recommendations
Roche price target raised to CHF 345 from CHF 330 at UBS » 13:53
07/19/21
07/19
13:53
07/19/21
13:53
RHHBY

Roche

$48.63 /

+0.23 (+0.48%)

UBS analyst Michael…

UBS analyst Michael Leuchten raised the firm's price target on Roche to CHF 345 from CHF 330 and keeps a Neutral rating on the shares.

ShowHide Related Items >><<
RHHBY Roche
$48.63 /

+0.23 (+0.48%)

RHHBY Roche
$48.63 /

+0.23 (+0.48%)

07/14/21 Jefferies
Roche upgraded to Buy from Hold at Jefferies
07/13/21 Piper Sandler
Bicycle Therapeutics price target raised to $46 from $39 at Piper Sandler
07/08/21 Deutsche Bank
Roche upgraded to Buy from Hold at Deutsche Bank
06/30/21 Jefferies
Pieris Pharmaceuticals price target raised to $8 from $6 at Jefferies
RHHBY Roche
$48.63 /

+0.23 (+0.48%)

RHHBY Roche
$48.63 /

+0.23 (+0.48%)

RHHBY Roche
$48.63 /

+0.23 (+0.48%)

Hot Stocks
Genentech announces results from final analysis of STASEY study » 05:36
07/19/21
07/19
05:36
07/19/21
05:36
RHHBY

Roche

$48.63 /

+0.23 (+0.48%)

Genentech, a member of…

Genentech, a member of Roche, announced results from the final analysis of the Phase IIIb STASEY study, which confirm the favorable safety profile of Hemlibra, consistent with the Phase III HAVEN clinical program. In the analysis, no new safety signals were identified with longer-term Hemlibra treatment in adults and adolescents with hemophilia A with inhibitors to factor VIII, the clotting protein that is missing or defective in people with hemophilia A. The data were presented at the virtual International Society on Thrombosis and Haemostasis, or ISTH, 2021 Congress. The final analysis of the STASEY study included data from 193 people with hemophilia A with factor VIII inhibitors who received Hemlibra prophylaxis once-weekly for up to two years. The analysis did not show any new cases of thrombotic microangiopathy or serious thrombotic events related to Hemlibra. The most common AEs occurring in 10% or more of people in the STASEY study were joint pain, common cold symptoms, headache, injection site reaction, or ISR, and fever. Thirty-five people reported a Hemlibra-related AE, with ISRs being the most common. In addition, the STASEY study reinforced that Hemlibra is associated with a low incidence of anti-drug antibody, or ADA, development. Ten participants tested positive for ADAs, five of whom were classified as having ADAs that were neutralizing in vitro. In all 10 participants, ADA development did not affect the efficacy or safety of Hemlibra; none of the participants had ADAs that resulted in a decrease in Hemlibra plasma concentration, and none of the ADA-positive participants experienced a treated bleed. In addition, the ADAs disappeared over time, as all study participants tested negative for ADAs at their last visit. Hemlibra also continued to demonstrate effective bleed control in the STASEY study, with 82.6% of participants experiencing no bleeding episodes that required treatment. Annualized bleeding rates were consistent with previously reported observations from the pivotal HAVEN studies.

ShowHide Related Items >><<
RHHBY Roche
$48.63 /

+0.23 (+0.48%)

RHHBY Roche
$48.63 /

+0.23 (+0.48%)

07/14/21 Jefferies
Roche upgraded to Buy from Hold at Jefferies
07/13/21 Piper Sandler
Bicycle Therapeutics price target raised to $46 from $39 at Piper Sandler
07/08/21 Deutsche Bank
Roche upgraded to Buy from Hold at Deutsche Bank
06/30/21 Jefferies
Pieris Pharmaceuticals price target raised to $8 from $6 at Jefferies
RHHBY Roche
$48.63 /

+0.23 (+0.48%)

RHHBY Roche
$48.63 /

+0.23 (+0.48%)

RHHBY Roche
$48.63 /

+0.23 (+0.48%)

Over a week ago
On The Fly
Wall Street in Fives - Must Read Lists for Thursday » 16:28
07/15/21
07/15
16:28
07/15/21
16:28
BCE

BCE

$49.46 /

-0.395 (-0.79%)

, RCI

Rogers Communications

$52.84 /

-0.59 (-1.10%)

, TU

Telus

$22.19 /

-0.28 (-1.25%)

, CGEAF

Cogeco Communications

$95.31 /

-2.39762 (-2.45%)

, QBCRF

Quebecor

$26.10 /

-0.4 (-1.51%)

, MS

Morgan Stanley

$92.62 /

+0.18 (+0.19%)

, TSM

TSMC

$117.34 /

-7.065 (-5.68%)

, PGR

Progressive

$94.95 /

-2.5198 (-2.59%)

, AIG

AIG

$48.06 /

+1.65 (+3.56%)

, BX

Blackstone

$102.48 /

+3.845 (+3.90%)

, AVASF

Avast

$8.20 /

+1.15 (+16.31%)

, AMD

AMD

$86.92 /

-2.14 (-2.40%)

, NXPI

NXP Semiconductors

$194.42 /

-8.86 (-4.36%)

, DAL

Delta Air Lines

$41.34 /

+0.65 (+1.60%)

, SQ

Square

$235.22 /

-3.7 (-1.55%)

, AAPL

Apple

$148.47 /

-0.77 (-0.52%)

, NFLX

Netflix

$542.97 /

-4.77 (-0.87%)

, BIIB

Biogen

$328.32 /

-23.74 (-6.74%)

, V

Visa

$248.62 /

+2.59 (+1.05%)

, MA

MasterCard

$390.32 /

-0.29 (-0.07%)

, PYPL

PayPal

$296.58 /

-4.12 (-1.37%)

, SCPL

SciPlay

$16.95 /

+1.56 (+10.14%)

, SGMS

Scientific Games

$64.41 /

-3.695 (-5.43%)

, NKLA

Nikola

$14.28 /

+0.39 (+2.81%)

, RTPY

Reinvent Technology Partners Y

$10.00 /

+0.15 (+1.52%)

, SAVA

Cassava Sciences

$82.42 /

-14.5 (-14.96%)

, AUR

Aurora Innovation

/

+

, GLPG

Galapagos

$57.23 /

-8.555 (-13.01%)

, UNH

UnitedHealth

$419.93 /

+5.09 (+1.23%)

, USB

U.S. Bancorp

$58.85 /

+1.82 (+3.19%)

, BK

BNY Mellon

$48.66 /

-0.62 (-1.26%)

, CTAS

Cintas

$368.87 /

-8.67 (-2.30%)

, ZYXI

Zynex

$15.19 /

+0.92 (+6.45%)

, NLOK

NortonLifeLock

$25.86 /

-1.06 (-3.94%)

Get caught up quickly on…

ShowHide Related Items >><<
ZYXI Zynex
$15.19 /

+0.92 (+6.45%)

V Visa
$248.62 /

+2.59 (+1.05%)

USB U.S. Bancorp
$58.85 /

+1.82 (+3.19%)

UNH UnitedHealth
$419.93 /

+5.09 (+1.23%)

TU Telus
$22.19 /

-0.28 (-1.25%)

TSM TSMC
$117.34 /

-7.065 (-5.68%)

SQ Square
$235.22 /

-3.7 (-1.55%)

SGMS Scientific Games
$64.41 /

-3.695 (-5.43%)

SCPL SciPlay
$16.95 /

+1.56 (+10.14%)

SAVA Cassava Sciences
$82.42 /

-14.5 (-14.96%)

RTPY Reinvent Technology Partners Y
$10.00 /

+0.15 (+1.52%)

RCI Rogers Communications
$52.84 /

-0.59 (-1.10%)

PYPL PayPal
$296.58 /

-4.12 (-1.37%)

PGR Progressive
$94.95 /

-2.5198 (-2.59%)

NXPI NXP Semiconductors
$194.42 /

-8.86 (-4.36%)

NLOK NortonLifeLock
$25.86 /

-1.06 (-3.94%)

NKLA Nikola
$14.28 /

+0.39 (+2.81%)

NFLX Netflix
$542.97 /

-4.77 (-0.87%)

MS Morgan Stanley
$92.62 /

+0.18 (+0.19%)

MA MasterCard
$390.32 /

-0.29 (-0.07%)

GLPG Galapagos
$57.23 /

-8.555 (-13.01%)

DAL Delta Air Lines
$41.34 /

+0.65 (+1.60%)

CTAS Cintas
$368.87 /

-8.67 (-2.30%)

CGEAF Cogeco Communications
$95.31 /

-2.39762 (-2.45%)

BX Blackstone
$102.48 /

+3.845 (+3.90%)

BK BNY Mellon
$48.66 /

-0.62 (-1.26%)

BIIB Biogen
$328.32 /

-23.74 (-6.74%)

BCE BCE
$49.46 /

-0.395 (-0.79%)

AVASF Avast
$8.20 /

+1.15 (+16.31%)

AMD AMD
$86.92 /

-2.14 (-2.40%)

AIG AIG
$48.06 /

+1.65 (+3.56%)

AAPL Apple
$148.47 /

-0.77 (-0.52%)

BCE BCE
$49.46 /

-0.395 (-0.79%)

05/03/21 Desjardins
BCE price target raised to C$62 from C$61 at Desjardins
04/30/21 Canaccord
BCE price target raised to C$59 from C$58 at Canaccord
04/30/21 RBC Capital
BCE price target raised to C$60 from C$59 at RBC Capital
04/30/21 TD Securities
BCE price target raised to C$64 from C$62 at TD Securities
RCI Rogers Communications
$52.84 /

-0.59 (-1.10%)

04/23/21 Desjardins
Rogers Communications price target raised to C$76 from C$74 at Desjardins
04/22/21 Canaccord
Rogers Communications price target lowered to C$71 from C$72 at Canaccord
04/22/21 National Bank
Rogers Communications price target raised to C$75 from C$74 at National Bank
04/22/21 RBC Capital
Rogers Communications price target raised to C$75 from C$74 at RBC Capital
TU Telus
$22.19 /

-0.28 (-1.25%)

05/10/21 CIBC
Telus price target raised to C$29 from C$28 at CIBC
05/10/21 Barclays
Telus price target raised to $24 from $21 at Barclays
04/05/21 TD Securities
Telus price target lowered to C$30 from C$31 at TD Securities
04/01/21 National Bank
Telus price target lowered to C$28 from C$29 at National Bank
CGEAF Cogeco Communications
$95.31 /

-2.39762 (-2.45%)

07/01/21 BMO Capital
Cogeco Communications price target raised to C$130 from C$125 at BMO Capital
06/30/21 National Bank
Cogeco Communications price target raised to C$143 from C$130 at National Bank
04/07/21 National Bank
Cogeco Communications price target raised to C$130 from C$126 at National Bank
03/22/21 Desjardins
Cogeco Communications assumed with a Hold at Desjardins
QBCRF Quebecor
$26.10 /

-0.4 (-1.51%)

05/14/21 Scotiabank
Quebecor price target lowered to C$38 from C$39 at Scotiabank
05/14/21 TD Securities
Quebecor price target raised to C$40 from C$39 at TD Securities
05/11/21 RBC Capital
Quebecor price target raised to C$41 from C$39 at RBC Capital
03/22/21 Desjardins
Quebecor assumed with a Buy at Desjardins
MS Morgan Stanley
$92.62 /

+0.18 (+0.19%)

07/16/21 Piper Sandler
Morgan Stanley price target raised to $100 from $93 at Piper Sandler
07/16/21 Oppenheimer
Morgan Stanley price target raised to $105 from $99 at Oppenheimer
07/07/21 RBC Capital
Morgan Stanley price target raised to $97 from $82 at RBC Capital
07/06/21 Keefe Bruyette
Morgan Stanley assumed with an Outperform at Keefe Bruyette
TSM TSMC
$117.34 /

-7.065 (-5.68%)

07/06/21 Citi
Intel outsourcing chips to TSMC will help gain back share, says Citi
06/30/21
Fly Intel: Top five analyst upgrades
06/30/21 Susquehanna
TSMC upgraded to Neutral from Negative at Susquehanna
06/22/21
Fly Intel: Top five analyst initiations
PGR Progressive
$94.95 /

-2.5198 (-2.59%)

07/16/21 Barclays
Progressive price target lowered to $84 from $86 at Barclays
07/09/21 BofA
Progressive added to US 1 List; Arch Capital removed at BofA
06/17/21 MKM Partners
Progressive investors should focus on strong PIF growth, says MKM Partners
06/17/21 BofA
Progressive price target lowered to $123 from $127 at BofA
AIG AIG
$48.06 /

+1.65 (+3.56%)

05/10/21 Barclays
AIG price target raised to $53 from $47 at Barclays
05/10/21 RBC Capital
AIG price target raised to $58 from $52 at RBC Capital
04/05/21 JPMorgan
AIG price target raised to $48 from $39 at JPMorgan
04/01/21 RBC Capital
AIG price target raised to $52 from $49 at RBC Capital
BX Blackstone
$102.48 /

+3.845 (+3.90%)

07/15/21 Citi
Blackstone price target raised to $103.50 from $100 at Citi
07/12/21 Deutsche Bank
Blackstone price target raised to $86 from $79 at Deutsche Bank
07/12/21 Citi
Blackstone price target raised to $100 from $91 at Citi
06/07/21 MoffettNathanson
QTS Realty buyout 'very appealing result,' says MoffettNathanson
AVASF Avast
$8.20 /

+1.15 (+16.31%)

04/21/21 Canaccord
Avast initiated with a Buy at Canaccord
03/08/21 BofA
Avast downgraded to Neutral from Buy at BofA
03/04/21 Barclays
Avast price target lowered to 565 GBp from 590 GBp at Barclays
03/04/21 Morgan Stanley
Avast price target lowered to 595 GBp from 610 GBp at Morgan Stanley
AMD AMD
$86.92 /

-2.14 (-2.40%)

07/15/21
Fly Intel: Top five analyst upgrades
07/15/21 Citi
AMD upgraded to Neutral from Sell at Citi
07/01/21 BMO Capital
Nvidia price target raised to $1,000 from $750 at BMO Capital
NXPI NXP Semiconductors
$194.42 /

-8.86 (-4.36%)

07/15/21
Fly Intel: Top five analyst downgrades
07/15/21 Mizuho
NXP Semiconductors downgraded to Neutral from Buy at Mizuho
05/17/21 Citi
Semis likely to trade lower near-term, but buy the dip, says Citi
04/28/21 KeyBanc
NXP Semiconductors price target raised to $235 from $225 at KeyBanc
DAL Delta Air Lines
$41.34 /

+0.65 (+1.60%)

07/15/21 Morgan Stanley
Delta shares deserve to be trading 'significantly higher,' says Morgan Stanley
07/15/21 Susquehanna
Delta Air Lines price target lowered to $45 from $53 at Susquehanna
07/15/21 Raymond James
Delta Air Lines double upgraded to Strong Buy at Raymond James
SQ Square
$235.22 /

-3.7 (-1.55%)

07/15/21 Mizuho
Buying Square could be like buying JPMorgan in 1871, says Mizuho
07/09/21 DA Davidson
DA Davidson says buy Square on any BTC-related weakness
06/24/21 Mizuho
Marqeta initiated with a Neutral at Mizuho
06/24/21 DA Davidson
Square initiated with a Buy at DA Davidson
AAPL Apple
$148.47 /

-0.77 (-0.52%)

07/15/21 Morgan Stanley
Apple price target raised to $166 at Morgan Stanley ahead of Q3 earnings
07/14/21 Stephens
Competitor like Apple 'significantly dents' Affirm growth story, says Stephens
07/14/21 JPMorgan
JPMorgan adds Apple to Analyst Focus List, boosts price target
07/14/21 Barclays
Apple Pay competitive concerns around Affirm overblown, says Barclays
NFLX Netflix
$542.97 /

-4.77 (-0.87%)

07/15/21 Wedbush
Competition to limit Netflix ability to grow free cash flow faster, says Wedbush
07/15/21 UBS
Netflix price target raised to $620 from $600 at UBS
07/13/21 KeyBanc
D2C video services best positioned to capture industry economics, says KeyBanc
07/12/21 JPMorgan
Netflix expectations, sentiment 'remain fairly muted,' says JPMorgan
BIIB Biogen
$328.32 /

-23.74 (-6.74%)

07/13/21 Oppenheimer
Prothena price target raised to $76 from $54 at Oppenheimer
07/09/21 Stifel
FDA call for probe 'noise' for Biogen, unlikely to impact Aduhelm, says Stifel
07/08/21 Deutsche Bank
Roche upgraded to Buy from Hold at Deutsche Bank
06/28/21 RBC Capital
Biogen price target lowered to $354 from $400 at RBC Capital
V Visa
$248.62 /

+2.59 (+1.05%)

07/15/21 Evercore ISI
Visa added to Tactical Outperform List at Evercore ISI
07/15/21 Baird
Visa price target raised to $305 from $282 at Baird
07/15/21 Baird
Visa price target raised to $305 from $282 at Baird
06/08/21 Credit Suisse
Visa price target raised to $285 from $280 at Credit Suisse
MA MasterCard
$390.32 /

-0.29 (-0.07%)

07/15/21 Evercore ISI
MasterCard added to Tactical Outperform List at Evercore ISI
07/15/21 Baird
MasterCard price target raised to $482 from $454
07/15/21 Baird
MasterCard price target raised to $482 from $454
06/07/21 Barclays
MasterCard price target raised to $452 from $440 at Barclays
PYPL PayPal
$296.58 /

-4.12 (-1.37%)

07/14/21 Susquehanna
PayPal price target raised to $360 from $330 at Susquehanna
07/13/21 Truist
Affirm shares overreacting to headline risk of Apple competition, says Truist
07/09/21 Evercore ISI
PayPal price target raised to $370 from $313 at Evercore ISI
07/08/21 Deutsche Bank
PayPal price target raised to $360 from $310 at Deutsche Bank
SCPL SciPlay
$16.95 /

+1.56 (+10.14%)

07/16/21 Truist
SciPlay downgraded to Hold from Buy at Truist
06/29/21 Truist
Scientific Games could look to consolidate SciPlay, says Truist
05/10/21 Wedbush
Wedbush still bullish on SciPlay after Q1 results, sees modest growth in 2021
03/02/21 Macquarie
SciPlay price target raised to $25 from $23 at Macquarie
SGMS Scientific Games
$64.41 /

-3.695 (-5.43%)

07/01/21 Macquarie
Scientific Games divestiture positive for International Game, says Macquarie
06/30/21 Jefferies
Scientific Games price target raised to $95 from $62 at Jefferies
06/30/21 Truist
Scientific Games price target raised to $90 from $68 at Truist
NKLA Nikola
$14.28 /

+0.39 (+2.81%)

06/08/21 Colliers
California HVIP vouchers 'an important development' for EV stocks, says Colliers
05/28/21
Fly Intel: Top five analyst initiations
05/27/21 BTIG
Nikola initiated with a Buy at BTIG
05/10/21 Deutsche Bank
Nikola price target lowered to $16 from $19 at Deutsche Bank
RTPY Reinvent Technology Partners Y
$10.00 /

+0.15 (+1.52%)

SAVA Cassava Sciences
$82.42 /

-14.5 (-14.96%)

07/15/21 Cantor Fitzgerald
Cassava Sciences downgraded to Neutral from Overweight at Cantor Fitzgerald
06/23/21 B. Riley
Cassava Sciences price target raised to $111 from $78 at B. Riley
04/27/21 B. Riley
B. Riley starts Cassava Sciences at Buy on Alzheimer's focus
AUR Aurora Innovation
/

+

GLPG Galapagos
$57.23 /

-8.555 (-13.01%)

06/07/21 Barclays
Galapagos price target lowered to EUR 75 from EUR 80 at Barclays
05/11/21 JPMorgan
Galapagos price target lowered to EUR from EUR 66 at JPMorgan
04/20/21 Deutsche Bank
Galapagos initiated with a Buy at Deutsche Bank
04/14/21 Barclays
Galapagos upgraded to Overweight from Equal Weight at Barclays
UNH UnitedHealth
$419.93 /

+5.09 (+1.23%)

07/16/21 Barclays
UnitedHealth price target raised to $465 from $435 at Barclays
07/09/21 Seaport Global
Seaport Global initiates five in Managed Care with three Buys
07/09/21 Seaport Global
UnitedHealth initiated with a Buy at Seaport Global
07/07/21 Citi
Citi sees policy change being narrowly applied, keeps Buy on MultiPlan
USB U.S. Bancorp
$58.85 /

+1.82 (+3.19%)

07/16/21 Oppenheimer
U.S. Bancorp price target raised to $73 from $70 at Oppenheimer
07/16/21 Barclays
U.S. Bancorp price target raised to $68 from $65 at Barclays
07/06/21 Keefe Bruyette
U.S. Bancorp assumed with an Outperform at Keefe Bruyette
05/18/21 Compass Point
U.S. Bancorp price target raised to $61 from $59 at Compass Point
BK BNY Mellon
$48.66 /

-0.62 (-1.26%)

06/29/21 Evercore ISI
Evercore says Morgan Stanley the 'standout' on capital plan among DFAST banks
06/17/21
Fly Intel: Top five analyst upgrades
06/17/21 Keefe Bruyette
BNY Mellon upgraded to Outperform from Market Perform at Keefe Bruyette
04/21/21 Citi
BNY Mellon price target lowered to $56 from $58 at Citi
CTAS Cintas
$368.87 /

-8.67 (-2.30%)

07/16/21 Baird
Cintas upgraded to Outperform from Neutral at Baird
07/16/21 Barclays
Cintas price target raised to $415 from $405 at Barclays
06/22/21 Goldman Sachs
Cintas price target raised to $411 from $387 at Goldman Sachs
02/16/21 William Blair
Cintas upgraded to Outperform from Market Perform at William Blair
ZYXI Zynex
$15.19 /

+0.92 (+6.45%)

07/16/21 B. Riley
Zynex upgraded to Buy from Neutral at B. Riley
07/15/21 Piper Sandler
Piper Sandler remains on the sidelines after Zynex preliminary quarterly results
04/29/21 Piper Sandler
Zynex price target lowered to $15 from $19 at Piper Sandler
03/09/21 Northland
Zynex upgraded to Outperform from Market Perform at Northland
NLOK NortonLifeLock
$25.86 /

-1.06 (-3.94%)

07/15/21 Barclays
NortonLifeLock price target raised to $32 from $31 at Barclays
05/27/21 Argus
NortonLifeLock price target raised to $32 from $27 at Argus
05/12/21 BofA
NortonLifeLock double-upgraded to Buy from Underperform at BofA
05/11/21 Barclays
NortonLifeLock price target raised to $31 from $27 at Barclays
ZYXI Zynex
$15.19 /

+0.92 (+6.45%)

V Visa
$248.62 /

+2.59 (+1.05%)

USB U.S. Bancorp
$58.85 /

+1.82 (+3.19%)

UNH UnitedHealth
$419.93 /

+5.09 (+1.23%)

TU Telus
$22.19 /

-0.28 (-1.25%)

TSM TSMC
$117.34 /

-7.065 (-5.68%)

SQ Square
$235.22 /

-3.7 (-1.55%)

SGMS Scientific Games
$64.41 /

-3.695 (-5.43%)

SCPL SciPlay
$16.95 /

+1.56 (+10.14%)

SAVA Cassava Sciences
$82.42 /

-14.5 (-14.96%)

RCI Rogers Communications
$52.84 /

-0.59 (-1.10%)

PYPL PayPal
$296.58 /

-4.12 (-1.37%)

PGR Progressive
$94.95 /

-2.5198 (-2.59%)

NXPI NXP Semiconductors
$194.42 /

-8.86 (-4.36%)

NLOK NortonLifeLock
$25.86 /

-1.06 (-3.94%)

NKLA Nikola
$14.28 /

+0.39 (+2.81%)

NFLX Netflix
$542.97 /

-4.77 (-0.87%)

MS Morgan Stanley
$92.62 /

+0.18 (+0.19%)

MA MasterCard
$390.32 /

-0.29 (-0.07%)

GLPG Galapagos
$57.23 /

-8.555 (-13.01%)

DAL Delta Air Lines
$41.34 /

+0.65 (+1.60%)

CTAS Cintas
$368.87 /

-8.67 (-2.30%)

BX Blackstone
$102.48 /

+3.845 (+3.90%)

BK BNY Mellon
$48.66 /

-0.62 (-1.26%)

BIIB Biogen
$328.32 /

-23.74 (-6.74%)

BCE BCE
$49.46 /

-0.395 (-0.79%)

AMD AMD
$86.92 /

-2.14 (-2.40%)

AIG AIG
$48.06 /

+1.65 (+3.56%)

AAPL Apple
$148.47 /

-0.77 (-0.52%)

  • 26
    Mar
  • 13
    Nov
  • 13
    Oct
V Visa
$248.62 /

+2.59 (+1.05%)

USB U.S. Bancorp
$58.85 /

+1.82 (+3.19%)

TSM TSMC
$117.34 /

-7.065 (-5.68%)

SQ Square
$235.22 /

-3.7 (-1.55%)

SGMS Scientific Games
$64.41 /

-3.695 (-5.43%)

RTPY Reinvent Technology Partners Y
$10.00 /

+0.15 (+1.52%)

RCI Rogers Communications
$52.84 /

-0.59 (-1.10%)

PYPL PayPal
$296.58 /

-4.12 (-1.37%)

PGR Progressive
$94.95 /

-2.5198 (-2.59%)

NXPI NXP Semiconductors
$194.42 /

-8.86 (-4.36%)

NLOK NortonLifeLock
$25.86 /

-1.06 (-3.94%)

NKLA Nikola
$14.28 /

+0.39 (+2.81%)

NFLX Netflix
$542.97 /

-4.77 (-0.87%)

MS Morgan Stanley
$92.62 /

+0.18 (+0.19%)

MA MasterCard
$390.32 /

-0.29 (-0.07%)

GLPG Galapagos
$57.23 /

-8.555 (-13.01%)

DAL Delta Air Lines
$41.34 /

+0.65 (+1.60%)

BX Blackstone
$102.48 /

+3.845 (+3.90%)

BK BNY Mellon
$48.66 /

-0.62 (-1.26%)

BIIB Biogen
$328.32 /

-23.74 (-6.74%)

BCE BCE
$49.46 /

-0.395 (-0.79%)

AVASF Avast
$8.20 /

+1.15 (+16.31%)

AMD AMD
$86.92 /

-2.14 (-2.40%)

AIG AIG
$48.06 /

+1.65 (+3.56%)

AAPL Apple
$148.47 /

-0.77 (-0.52%)

V Visa
$248.62 /

+2.59 (+1.05%)

USB U.S. Bancorp
$58.85 /

+1.82 (+3.19%)

UNH UnitedHealth
$419.93 /

+5.09 (+1.23%)

TU Telus
$22.19 /

-0.28 (-1.25%)

TSM TSMC
$117.34 /

-7.065 (-5.68%)

SQ Square
$235.22 /

-3.7 (-1.55%)

SGMS Scientific Games
$64.41 /

-3.695 (-5.43%)

SCPL SciPlay
$16.95 /

+1.56 (+10.14%)

SAVA Cassava Sciences
$82.42 /

-14.5 (-14.96%)

RTPY Reinvent Technology Partners Y
$10.00 /

+0.15 (+1.52%)

RCI Rogers Communications
$52.84 /

-0.59 (-1.10%)

PYPL PayPal
$296.58 /

-4.12 (-1.37%)

NXPI NXP Semiconductors
$194.42 /

-8.86 (-4.36%)

NKLA Nikola
$14.28 /

+0.39 (+2.81%)

MS Morgan Stanley
$92.62 /

+0.18 (+0.19%)

MA MasterCard
$390.32 /

-0.29 (-0.07%)

GLPG Galapagos
$57.23 /

-8.555 (-13.01%)

DAL Delta Air Lines
$41.34 /

+0.65 (+1.60%)

CTAS Cintas
$368.87 /

-8.67 (-2.30%)

BX Blackstone
$102.48 /

+3.845 (+3.90%)

BK BNY Mellon
$48.66 /

-0.62 (-1.26%)

BIIB Biogen
$328.32 /

-23.74 (-6.74%)

BCE BCE
$49.46 /

-0.395 (-0.79%)

AMD AMD
$86.92 /

-2.14 (-2.40%)

AIG AIG
$48.06 /

+1.65 (+3.56%)

AAPL Apple
$148.47 /

-0.77 (-0.52%)

ZYXI Zynex
$15.19 /

+0.92 (+6.45%)

V Visa
$248.62 /

+2.59 (+1.05%)

USB U.S. Bancorp
$58.85 /

+1.82 (+3.19%)

UNH UnitedHealth
$419.93 /

+5.09 (+1.23%)

TSM TSMC
$117.34 /

-7.065 (-5.68%)

SQ Square
$235.22 /

-3.7 (-1.55%)

SGMS Scientific Games
$64.41 /

-3.695 (-5.43%)

SAVA Cassava Sciences
$82.42 /

-14.5 (-14.96%)

PYPL PayPal
$296.58 /

-4.12 (-1.37%)

PGR Progressive
$94.95 /

-2.5198 (-2.59%)

NXPI NXP Semiconductors
$194.42 /

-8.86 (-4.36%)

NLOK NortonLifeLock
$25.86 /

-1.06 (-3.94%)

NKLA Nikola
$14.28 /

+0.39 (+2.81%)

NFLX Netflix
$542.97 /

-4.77 (-0.87%)

MS Morgan Stanley
$92.62 /

+0.18 (+0.19%)

MA MasterCard
$390.32 /

-0.29 (-0.07%)

DAL Delta Air Lines
$41.34 /

+0.65 (+1.60%)

BX Blackstone
$102.48 /

+3.845 (+3.90%)

BIIB Biogen
$328.32 /

-23.74 (-6.74%)

AMD AMD
$86.92 /

-2.14 (-2.40%)

AIG AIG
$48.06 /

+1.65 (+3.56%)

AAPL Apple
$148.47 /

-0.77 (-0.52%)

On The Fly
Wall Street in Fives - Must Read Lists at Midday » 13:16
07/15/21
07/15
13:16
07/15/21
13:16
MS

Morgan Stanley

$92.41 /

-0.03 (-0.03%)

, TSM

TSMC

$117.47 /

-6.935 (-5.57%)

, PGR

Progressive

$94.60 /

-2.87 (-2.94%)

, AIG

AIG

$47.74 /

+1.33 (+2.87%)

, BX

Blackstone

$101.48 /

+2.85 (+2.89%)

, AVASF

Avast

$7.05 /

+0.0674 (+0.97%)

, NLOK

NortonLifeLock

$25.85 /

-1.07 (-3.97%)

, NFLX

Netflix

$540.89 /

-6.85 (-1.25%)

, BIIB

Biogen

$328.06 /

-24 (-6.82%)

, RTPY

Reinvent Technology Partners Y

$10.04 /

+0.19 (+1.93%)

, V

Visa

$247.09 /

+1.06 (+0.43%)

, MA

MasterCard

$388.22 /

-2.39 (-0.61%)

, GPS

Gap

$29.70 /

-1.3 (-4.19%)

, SCPL

SciPlay

$17.33 /

+1.94 (+12.61%)

, SGMS

Scientific Games

$65.15 /

-2.95 (-4.33%)

, NKLA

Nikola

$14.26 /

+0.37 (+2.66%)

, SAVA

Cassava Sciences

$83.51 /

-13.41 (-13.84%)

, GATO

Gatos Silver

$13.66 /

-0.85 (-5.86%)

, HON

Honeywell

$231.72 /

+3.95 (+1.73%)

, UNH

UnitedHealth

$420.15 /

+5.31 (+1.28%)

, USB

U.S. Bancorp

$59.00 /

+1.97 (+3.45%)

, BK

BNY Mellon

$48.79 /

-0.495 (-1.00%)

, CTAS

Cintas

$369.24 /

-8.3 (-2.20%)

, ZYXI

Zynex

$15.26 /

+0.99 (+6.94%)

, NXPI

NXP Semiconductors

$194.03 /

-9.25 (-4.55%)

, DAL

Delta Air Lines

$41.30 /

+0.61 (+1.50%)

, SQ

Square

$234.88 /

-4.04 (-1.69%)

, AAPL

Apple

$147.81 /

-1.43 (-0.96%)

, AMD

AMD

$87.21 /

-1.85 (-2.08%)

, GLPG

Galapagos

$57.72 /

-8.06 (-12.25%)

Get caught up quickly on…

ShowHide Related Items >><<
ZYXI Zynex
$15.26 /

+0.99 (+6.94%)

V Visa
$247.09 /

+1.06 (+0.43%)

USB U.S. Bancorp
$59.00 /

+1.97 (+3.45%)

UNH UnitedHealth
$420.15 /

+5.31 (+1.28%)

TSM TSMC
$117.47 /

-6.935 (-5.57%)

SQ Square
$234.88 /

-4.04 (-1.69%)

SGMS Scientific Games
$65.15 /

-2.95 (-4.33%)

SCPL SciPlay
$17.33 /

+1.94 (+12.61%)

SAVA Cassava Sciences
$83.51 /

-13.41 (-13.84%)

RTPY Reinvent Technology Partners Y
$10.04 /

+0.19 (+1.93%)

PGR Progressive
$94.60 /

-2.87 (-2.94%)

NXPI NXP Semiconductors
$194.03 /

-9.25 (-4.55%)

NLOK NortonLifeLock
$25.85 /

-1.07 (-3.97%)

NKLA Nikola
$14.26 /

+0.37 (+2.66%)

NFLX Netflix
$540.89 /

-6.85 (-1.25%)

MS Morgan Stanley
$92.41 /

-0.03 (-0.03%)

MA MasterCard
$388.22 /

-2.39 (-0.61%)

HON Honeywell
$231.72 /

+3.95 (+1.73%)

GPS Gap
$29.70 /

-1.3 (-4.19%)

GLPG Galapagos
$57.72 /

-8.06 (-12.25%)

GATO Gatos Silver
$13.66 /

-0.85 (-5.86%)

DAL Delta Air Lines
$41.30 /

+0.61 (+1.50%)

CTAS Cintas
$369.24 /

-8.3 (-2.20%)

BX Blackstone
$101.48 /

+2.85 (+2.89%)

BK BNY Mellon
$48.79 /

-0.495 (-1.00%)

BIIB Biogen
$328.06 /

-24 (-6.82%)

AVASF Avast
$7.05 /

+0.0674 (+0.97%)

AMD AMD
$87.21 /

-1.85 (-2.08%)

AIG AIG
$47.74 /

+1.33 (+2.87%)

AAPL Apple
$147.81 /

-1.43 (-0.96%)

MS Morgan Stanley
$92.41 /

-0.03 (-0.03%)

07/07/21 RBC Capital
Morgan Stanley price target raised to $97 from $82 at RBC Capital
07/06/21 Keefe Bruyette
Morgan Stanley assumed with an Outperform at Keefe Bruyette
06/29/21 Evercore ISI
Evercore says Morgan Stanley the 'standout' on capital plan among DFAST banks
06/16/21 JPMorgan
Morgan Stanley price target raised to $105 from $85 at JPMorgan
TSM TSMC
$117.47 /

-6.935 (-5.57%)

07/06/21 Citi
Intel outsourcing chips to TSMC will help gain back share, says Citi
06/30/21
Fly Intel: Top five analyst upgrades
06/30/21 Susquehanna
TSMC upgraded to Neutral from Negative at Susquehanna
06/22/21
Fly Intel: Top five analyst initiations
PGR Progressive
$94.60 /

-2.87 (-2.94%)

07/09/21 BofA
Progressive added to US 1 List; Arch Capital removed at BofA
06/17/21 MKM Partners
Progressive investors should focus on strong PIF growth, says MKM Partners
06/17/21 BofA
Progressive price target lowered to $123 from $127 at BofA
06/07/21
Fly Intel: Top five analyst downgrades
AIG AIG
$47.74 /

+1.33 (+2.87%)

05/10/21 Barclays
AIG price target raised to $53 from $47 at Barclays
05/10/21 RBC Capital
AIG price target raised to $58 from $52 at RBC Capital
04/05/21 JPMorgan
AIG price target raised to $48 from $39 at JPMorgan
04/01/21 RBC Capital
AIG price target raised to $52 from $49 at RBC Capital
BX Blackstone
$101.48 /

+2.85 (+2.89%)

07/15/21 Citi
Blackstone price target raised to $103.50 from $100 at Citi
07/12/21 Deutsche Bank
Blackstone price target raised to $86 from $79 at Deutsche Bank
07/12/21 Citi
Blackstone price target raised to $100 from $91 at Citi
06/07/21 MoffettNathanson
QTS Realty buyout 'very appealing result,' says MoffettNathanson
AVASF Avast
$7.05 /

+0.0674 (+0.97%)

04/21/21 Canaccord
Avast initiated with a Buy at Canaccord
03/08/21 BofA
Avast downgraded to Neutral from Buy at BofA
03/04/21 Barclays
Avast price target lowered to 565 GBp from 590 GBp at Barclays
03/04/21 Morgan Stanley
Avast price target lowered to 595 GBp from 610 GBp at Morgan Stanley
NLOK NortonLifeLock
$25.85 /

-1.07 (-3.97%)

07/15/21 Barclays
NortonLifeLock price target raised to $32 from $31 at Barclays
05/27/21 Argus
NortonLifeLock price target raised to $32 from $27 at Argus
05/12/21 BofA
NortonLifeLock double-upgraded to Buy from Underperform at BofA
05/11/21 Barclays
NortonLifeLock price target raised to $31 from $27 at Barclays
NFLX Netflix
$540.89 /

-6.85 (-1.25%)

07/15/21 Wedbush
Competition to limit Netflix ability to grow free cash flow faster, says Wedbush
07/15/21 UBS
Netflix price target raised to $620 from $600 at UBS
07/13/21 KeyBanc
D2C video services best positioned to capture industry economics, says KeyBanc
07/12/21 JPMorgan
Netflix expectations, sentiment 'remain fairly muted,' says JPMorgan
BIIB Biogen
$328.06 /

-24 (-6.82%)

07/13/21 Oppenheimer
Prothena price target raised to $76 from $54 at Oppenheimer
07/09/21 Stifel
FDA call for probe 'noise' for Biogen, unlikely to impact Aduhelm, says Stifel
07/08/21 Deutsche Bank
Roche upgraded to Buy from Hold at Deutsche Bank
06/28/21 RBC Capital
Biogen price target lowered to $354 from $400 at RBC Capital
RTPY Reinvent Technology Partners Y
$10.04 /

+0.19 (+1.93%)

V Visa
$247.09 /

+1.06 (+0.43%)

07/15/21 Evercore ISI
Visa added to Tactical Outperform List at Evercore ISI
07/15/21 Baird
Visa price target raised to $305 from $282 at Baird
07/15/21 Baird
Visa price target raised to $305 from $282 at Baird
06/08/21 Credit Suisse
Visa price target raised to $285 from $280 at Credit Suisse
MA MasterCard
$388.22 /

-2.39 (-0.61%)

07/15/21 Evercore ISI
MasterCard added to Tactical Outperform List at Evercore ISI
07/15/21 Baird
MasterCard price target raised to $482 from $454
07/15/21 Baird
MasterCard price target raised to $482 from $454
06/07/21 Barclays
MasterCard price target raised to $452 from $440 at Barclays
GPS Gap
$29.70 /

-1.3 (-4.19%)

07/14/21 Goldman Sachs
Gap initiated with a Neutral at Goldman Sachs
07/06/21
Fly Intel: Top five analyst initiations
07/06/21 KGI Securities
Gap initiated with an Outperform at KGI Securities
07/01/21 Wells Fargo
Gap price target raised to $45 from $40 at Wells Fargo
SCPL SciPlay
$17.33 /

+1.94 (+12.61%)

06/29/21 Truist
Scientific Games could look to consolidate SciPlay, says Truist
05/10/21 Wedbush
Wedbush still bullish on SciPlay after Q1 results, sees modest growth in 2021
03/02/21 Macquarie
SciPlay price target raised to $25 from $23 at Macquarie
02/18/21 Deutsche Bank
SciPlay price target raised to $23 from $20 at Deutsche Bank
SGMS Scientific Games
$65.15 /

-2.95 (-4.33%)

07/01/21 Macquarie
Scientific Games divestiture positive for International Game, says Macquarie
06/30/21 Jefferies
Scientific Games price target raised to $95 from $62 at Jefferies
06/30/21 Truist
Scientific Games price target raised to $90 from $68 at Truist
06/30/21 Craig-Hallum
Scientific Games price target raised to $92 from $70 at Craig-Hallum
NKLA Nikola
$14.26 /

+0.37 (+2.66%)

06/08/21 Colliers
California HVIP vouchers 'an important development' for EV stocks, says Colliers
05/28/21
Fly Intel: Top five analyst initiations
05/27/21 BTIG
Nikola initiated with a Buy at BTIG
05/10/21 Deutsche Bank
Nikola price target lowered to $16 from $19 at Deutsche Bank
SAVA Cassava Sciences
$83.51 /

-13.41 (-13.84%)

07/15/21
Fly Intel: Top five analyst downgrades
07/15/21 Cantor Fitzgerald
Cassava Sciences downgraded to Neutral from Overweight at Cantor Fitzgerald
06/23/21 B. Riley
Cassava Sciences price target raised to $111 from $78 at B. Riley
04/27/21 B. Riley
B. Riley starts Cassava Sciences at Buy on Alzheimer's focus
GATO Gatos Silver
$13.66 /

-0.85 (-5.86%)

05/27/21 Canaccord
Gatos Silver initiated with a Buy at Canaccord
04/13/21 CIBC
Gatos Silver initiated with an Outperformer at CIBC
04/13/21 CIBC
Gatos Silver initiated with an Outperformer at CIBC
01/29/21 BMO Capital
Gatos Silver downgraded to Market Perform from Outperform at BMO Capital
HON Honeywell
$231.72 /

+3.95 (+1.73%)

07/14/21 Deutsche Bank
Honeywell price target lowered to $245 from $246 at Deutsche Bank
05/21/21 JPMorgan
Honeywell growth opportunities underappreciated, says JPMorgan's Tusa
04/26/21 Credit Suisse
Honeywell price target raised to $235 from $224 at Credit Suisse
04/26/21 Barclays
Honeywell price target raised to $245 from $230 at Barclays
UNH UnitedHealth
$420.15 /

+5.31 (+1.28%)

07/09/21 Seaport Global
Seaport Global initiates five in Managed Care with three Buys
07/09/21 Seaport Global
UnitedHealth initiated with a Buy at Seaport Global
07/07/21 Citi
Citi sees policy change being narrowly applied, keeps Buy on MultiPlan
05/21/21 Truist
UnitedHealth price target raised to $480 from $450 at Truist
USB U.S. Bancorp
$59.00 /

+1.97 (+3.45%)

07/06/21 Keefe Bruyette
U.S. Bancorp assumed with an Outperform at Keefe Bruyette
05/18/21 Compass Point
U.S. Bancorp price target raised to $61 from $59 at Compass Point
05/03/21 JPMorgan
U.S. Bancorp price target raised to $64.50 from $60 at JPMorgan
04/21/21 Citi
U.S. Bancorp price target raised to $63 from $55 at Citi
BK BNY Mellon
$48.79 /

-0.495 (-1.00%)

06/17/21
Fly Intel: Top five analyst upgrades
06/17/21 Keefe Bruyette
BNY Mellon upgraded to Outperform from Market Perform at Keefe Bruyette
04/21/21 Citi
BNY Mellon price target lowered to $56 from $58 at Citi
CTAS Cintas
$369.24 /

-8.3 (-2.20%)

06/22/21 Goldman Sachs
Cintas price target raised to $411 from $387 at Goldman Sachs
02/16/21 William Blair
Cintas upgraded to Outperform from Market Perform at William Blair
01/06/21
Fly Intel: Top five analyst upgrades
01/06/21 Morgan Stanley
Morgan Stanley upgrades 'solid compounder' Cintas to Equal Weight
ZYXI Zynex
$15.26 /

+0.99 (+6.94%)

07/15/21 Piper Sandler
Piper Sandler remains on the sidelines after Zynex preliminary quarterly results
04/29/21 Piper Sandler
Zynex price target lowered to $15 from $19 at Piper Sandler
03/09/21 Northland
Zynex upgraded to Outperform from Market Perform at Northland
02/26/21 B. Riley
B. Riley downgrades Zynex to Neutral on 'deteriorating profitability'
NXPI NXP Semiconductors
$194.03 /

-9.25 (-4.55%)

07/15/21 Mizuho
NXP Semiconductors downgraded to Neutral from Buy at Mizuho
05/17/21 Citi
Semis likely to trade lower near-term, but buy the dip, says Citi
04/28/21 KeyBanc
NXP Semiconductors price target raised to $235 from $225 at KeyBanc
DAL Delta Air Lines
$41.30 /

+0.61 (+1.50%)

07/15/21 Morgan Stanley
Delta shares deserve to be trading 'significantly higher,' says Morgan Stanley
07/15/21
Fly Intel: Top five analyst upgrades
07/15/21 Susquehanna
Delta Air Lines price target lowered to $45 from $53 at Susquehanna
07/15/21 Raymond James
Delta Air Lines double upgraded to Strong Buy at Raymond James
SQ Square
$234.88 /

-4.04 (-1.69%)

07/15/21 Mizuho
Buying Square could be like buying JPMorgan in 1871, says Mizuho
07/09/21 DA Davidson
DA Davidson says buy Square on any BTC-related weakness
06/24/21 Mizuho
Marqeta initiated with a Neutral at Mizuho
06/24/21 DA Davidson
Square initiated with a Buy at DA Davidson
AAPL Apple
$147.81 /

-1.43 (-0.96%)

07/15/21 Morgan Stanley
Apple price target raised to $166 at Morgan Stanley ahead of Q3 earnings
07/14/21 Stephens
Competitor like Apple 'significantly dents' Affirm growth story, says Stephens
07/14/21 JPMorgan
JPMorgan adds Apple to Analyst Focus List, boosts price target
07/14/21 Barclays
Apple Pay competitive concerns around Affirm overblown, says Barclays
AMD AMD
$87.21 /

-1.85 (-2.08%)

07/15/21 Citi
AMD upgraded to Neutral from Sell at Citi
07/01/21 BMO Capital
Nvidia price target raised to $1,000 from $750 at BMO Capital
GLPG Galapagos
$57.72 /

-8.06 (-12.25%)

06/07/21 Barclays
Galapagos price target lowered to EUR 75 from EUR 80 at Barclays
05/11/21 JPMorgan
Galapagos price target lowered to EUR from EUR 66 at JPMorgan
04/20/21 Deutsche Bank
Galapagos initiated with a Buy at Deutsche Bank
04/14/21 Barclays
Galapagos upgraded to Overweight from Equal Weight at Barclays
ZYXI Zynex
$15.26 /

+0.99 (+6.94%)

V Visa
$247.09 /

+1.06 (+0.43%)

USB U.S. Bancorp
$59.00 /

+1.97 (+3.45%)

UNH UnitedHealth
$420.15 /

+5.31 (+1.28%)

TSM TSMC
$117.47 /

-6.935 (-5.57%)

SQ Square
$234.88 /

-4.04 (-1.69%)

SGMS Scientific Games
$65.15 /

-2.95 (-4.33%)

SCPL SciPlay
$17.33 /

+1.94 (+12.61%)

SAVA Cassava Sciences
$83.51 /

-13.41 (-13.84%)

PGR Progressive
$94.60 /

-2.87 (-2.94%)

NXPI NXP Semiconductors
$194.03 /

-9.25 (-4.55%)

NLOK NortonLifeLock
$25.85 /

-1.07 (-3.97%)

NKLA Nikola
$14.26 /

+0.37 (+2.66%)

NFLX Netflix
$540.89 /

-6.85 (-1.25%)

MS Morgan Stanley
$92.41 /

-0.03 (-0.03%)

MA MasterCard
$388.22 /

-2.39 (-0.61%)

HON Honeywell
$231.72 /

+3.95 (+1.73%)

GPS Gap
$29.70 /

-1.3 (-4.19%)

GLPG Galapagos
$57.72 /

-8.06 (-12.25%)

DAL Delta Air Lines
$41.30 /

+0.61 (+1.50%)

CTAS Cintas
$369.24 /

-8.3 (-2.20%)

BX Blackstone
$101.48 /

+2.85 (+2.89%)

BK BNY Mellon
$48.79 /

-0.495 (-1.00%)

BIIB Biogen
$328.06 /

-24 (-6.82%)

AMD AMD
$87.21 /

-1.85 (-2.08%)

AIG AIG
$47.74 /

+1.33 (+2.87%)

AAPL Apple
$147.81 /

-1.43 (-0.96%)

  • 15
    Jul
  • 13
    Nov
  • 28
    Oct
  • 13
    Oct
V Visa
$247.09 /

+1.06 (+0.43%)

USB U.S. Bancorp
$59.00 /

+1.97 (+3.45%)

TSM TSMC
$117.47 /

-6.935 (-5.57%)

SQ Square
$234.88 /

-4.04 (-1.69%)

SGMS Scientific Games
$65.15 /

-2.95 (-4.33%)

RTPY Reinvent Technology Partners Y
$10.04 /

+0.19 (+1.93%)

PGR Progressive
$94.60 /

-2.87 (-2.94%)

NXPI NXP Semiconductors
$194.03 /

-9.25 (-4.55%)

NLOK NortonLifeLock
$25.85 /

-1.07 (-3.97%)

NKLA Nikola
$14.26 /

+0.37 (+2.66%)

NFLX Netflix
$540.89 /

-6.85 (-1.25%)

MS Morgan Stanley
$92.41 /

-0.03 (-0.03%)

MA MasterCard
$388.22 /

-2.39 (-0.61%)

GPS Gap
$29.70 /

-1.3 (-4.19%)

GLPG Galapagos
$57.72 /

-8.06 (-12.25%)

DAL Delta Air Lines
$41.30 /

+0.61 (+1.50%)

BX Blackstone
$101.48 /

+2.85 (+2.89%)

BK BNY Mellon
$48.79 /

-0.495 (-1.00%)

BIIB Biogen
$328.06 /

-24 (-6.82%)

AVASF Avast
$7.05 /

+0.0674 (+0.97%)

AMD AMD
$87.21 /

-1.85 (-2.08%)

AIG AIG
$47.74 /

+1.33 (+2.87%)

AAPL Apple
$147.81 /

-1.43 (-0.96%)

V Visa
$247.09 /

+1.06 (+0.43%)

USB U.S. Bancorp
$59.00 /

+1.97 (+3.45%)

UNH UnitedHealth
$420.15 /

+5.31 (+1.28%)

TSM TSMC
$117.47 /

-6.935 (-5.57%)

SQ Square
$234.88 /

-4.04 (-1.69%)

SGMS Scientific Games
$65.15 /

-2.95 (-4.33%)

SCPL SciPlay
$17.33 /

+1.94 (+12.61%)

SAVA Cassava Sciences
$83.51 /

-13.41 (-13.84%)

RTPY Reinvent Technology Partners Y
$10.04 /

+0.19 (+1.93%)

NXPI NXP Semiconductors
$194.03 /

-9.25 (-4.55%)

NKLA Nikola
$14.26 /

+0.37 (+2.66%)

NFLX Netflix
$540.89 /

-6.85 (-1.25%)

MS Morgan Stanley
$92.41 /

-0.03 (-0.03%)

MA MasterCard
$388.22 /

-2.39 (-0.61%)

HON Honeywell
$231.72 /

+3.95 (+1.73%)

GPS Gap
$29.70 /

-1.3 (-4.19%)

GLPG Galapagos
$57.72 /

-8.06 (-12.25%)

CTAS Cintas
$369.24 /

-8.3 (-2.20%)

BX Blackstone
$101.48 /

+2.85 (+2.89%)

BK BNY Mellon
$48.79 /

-0.495 (-1.00%)

BIIB Biogen
$328.06 /

-24 (-6.82%)

AVASF Avast
$7.05 /

+0.0674 (+0.97%)

AIG AIG
$47.74 /

+1.33 (+2.87%)

AAPL Apple
$147.81 /

-1.43 (-0.96%)

ZYXI Zynex
$15.26 /

+0.99 (+6.94%)

V Visa
$247.09 /

+1.06 (+0.43%)

USB U.S. Bancorp
$59.00 /

+1.97 (+3.45%)

UNH UnitedHealth
$420.15 /

+5.31 (+1.28%)

TSM TSMC
$117.47 /

-6.935 (-5.57%)

SQ Square
$234.88 /

-4.04 (-1.69%)

SGMS Scientific Games
$65.15 /

-2.95 (-4.33%)

SAVA Cassava Sciences
$83.51 /

-13.41 (-13.84%)

PGR Progressive
$94.60 /

-2.87 (-2.94%)

NXPI NXP Semiconductors
$194.03 /

-9.25 (-4.55%)

NLOK NortonLifeLock
$25.85 /

-1.07 (-3.97%)

NKLA Nikola
$14.26 /

+0.37 (+2.66%)

NFLX Netflix
$540.89 /

-6.85 (-1.25%)

MS Morgan Stanley
$92.41 /

-0.03 (-0.03%)

MA MasterCard
$388.22 /

-2.39 (-0.61%)

HON Honeywell
$231.72 /

+3.95 (+1.73%)

GPS Gap
$29.70 /

-1.3 (-4.19%)

GATO Gatos Silver
$13.66 /

-0.85 (-5.86%)

DAL Delta Air Lines
$41.30 /

+0.61 (+1.50%)

BX Blackstone
$101.48 /

+2.85 (+2.89%)

BIIB Biogen
$328.06 /

-24 (-6.82%)

AMD AMD
$87.21 /

-1.85 (-2.08%)

AIG AIG
$47.74 /

+1.33 (+2.87%)

AAPL Apple
$147.81 /

-1.43 (-0.96%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.